Efficacy and safety of low-molecular-weight heparin or rivaroxaban combined with immunotherapy and chemotherapy in the treatment of advanced nonsmall cell lung cancer: a prospective, randomized, controlled clinical study
Abstract Objective This study aimed to observe and compare the efficacy and safety of different anticoagulants combined with immunotherapy and chemotherapy for advanced nonsmall cell lung cancer (NSCLC). Methods In this prospective, randomized, controlled clinical trial, treatment-naïve subjects wit...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer
2025-11-01
|
| Col·lecció: | Cancer Immunology, Immunotherapy |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1007/s00262-025-04227-5 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|